Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP725484.RAJh5hPZrXVE2bY4zzBzmUCUG7FGItLPkckxA8shhxnIM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP725484.RAJh5hPZrXVE2bY4zzBzmUCUG7FGItLPkckxA8shhxnIM130_assertion type Assertion NP725484.RAJh5hPZrXVE2bY4zzBzmUCUG7FGItLPkckxA8shhxnIM130_head.
- NP725484.RAJh5hPZrXVE2bY4zzBzmUCUG7FGItLPkckxA8shhxnIM130_assertion wasGeneratedBy ECO_0000203 NP725484.RAJh5hPZrXVE2bY4zzBzmUCUG7FGItLPkckxA8shhxnIM130_provenance.
- NP725484.RAJh5hPZrXVE2bY4zzBzmUCUG7FGItLPkckxA8shhxnIM130_assertion wasDerivedFrom befree-20140225 NP725484.RAJh5hPZrXVE2bY4zzBzmUCUG7FGItLPkckxA8shhxnIM130_provenance.
- NP725484.RAJh5hPZrXVE2bY4zzBzmUCUG7FGItLPkckxA8shhxnIM130_assertion SIO_000772 18239620 NP725484.RAJh5hPZrXVE2bY4zzBzmUCUG7FGItLPkckxA8shhxnIM130_provenance.
- NP725484.RAJh5hPZrXVE2bY4zzBzmUCUG7FGItLPkckxA8shhxnIM130_assertion evidence source_evidence_literature NP725484.RAJh5hPZrXVE2bY4zzBzmUCUG7FGItLPkckxA8shhxnIM130_provenance.
- NP725484.RAJh5hPZrXVE2bY4zzBzmUCUG7FGItLPkckxA8shhxnIM130_assertion description "[MRD-based risk group assignment was feasible in 2594 (78%) patients: 40% were classified as MRD-SR (two sensitive targets, MRD negativity at both time points), 8% as MRD-HR (MRD > or =10(-3) at TP2), and 52% as MRD-IR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP725484.RAJh5hPZrXVE2bY4zzBzmUCUG7FGItLPkckxA8shhxnIM130_provenance.